IRIS
BRIGANTI, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 34.753
EU - Europa 32.537
NA - Nord America 22.779
SA - Sud America 10.436
AF - Africa 884
OC - Oceania 103
Continente sconosciuto - Info sul continente non disponibili 17
AN - Antartide 2
Totale 101.511
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.569
RU - Federazione Russa 18.736
SG - Singapore 12.820
CN - Cina 9.588
BR - Brasile 8.528
HK - Hong Kong 4.718
IT - Italia 4.029
SE - Svezia 3.696
VN - Vietnam 3.533
FR - Francia 1.812
DE - Germania 1.040
BD - Bangladesh 1.002
AR - Argentina 769
IN - India 650
GB - Regno Unito 600
FI - Finlandia 541
CA - Canada 516
ID - Indonesia 481
MX - Messico 374
NL - Olanda 355
EC - Ecuador 323
RO - Romania 286
IQ - Iraq 278
JP - Giappone 273
ZA - Sudafrica 261
ES - Italia 253
IE - Irlanda 244
TR - Turchia 230
CO - Colombia 229
PL - Polonia 189
AT - Austria 177
PY - Paraguay 149
PK - Pakistan 147
UA - Ucraina 130
CL - Cile 125
VE - Venezuela 124
MA - Marocco 114
MY - Malesia 110
EG - Egitto 95
UZ - Uzbekistan 95
SA - Arabia Saudita 92
PE - Perù 90
NP - Nepal 82
AU - Australia 80
AE - Emirati Arabi Uniti 74
TN - Tunisia 74
KE - Kenya 71
PH - Filippine 70
IR - Iran 63
JM - Giamaica 60
LT - Lituania 58
UY - Uruguay 58
DZ - Algeria 55
JO - Giordania 54
NG - Nigeria 54
DO - Repubblica Dominicana 46
IL - Israele 42
KZ - Kazakistan 38
AZ - Azerbaigian 37
CR - Costa Rica 37
CH - Svizzera 36
AL - Albania 34
BE - Belgio 34
BO - Bolivia 30
GR - Grecia 30
BG - Bulgaria 28
LB - Libano 28
KR - Corea 27
GT - Guatemala 26
TH - Thailandia 26
HN - Honduras 25
MD - Moldavia 25
PT - Portogallo 25
RS - Serbia 25
TW - Taiwan 25
CZ - Repubblica Ceca 24
NO - Norvegia 22
TT - Trinidad e Tobago 22
OM - Oman 21
SN - Senegal 21
BA - Bosnia-Erzegovina 20
PA - Panama 20
SV - El Salvador 20
BH - Bahrain 19
HU - Ungheria 18
TZ - Tanzania 17
KG - Kirghizistan 16
KH - Cambogia 16
NI - Nicaragua 15
PS - Palestinian Territory 15
BB - Barbados 14
NZ - Nuova Zelanda 14
AO - Angola 13
BY - Bielorussia 13
KW - Kuwait 13
PR - Porto Rico 13
SY - Repubblica araba siriana 13
CY - Cipro 12
ET - Etiopia 12
XK - ???statistics.table.value.countryCode.XK??? 11
Totale 101.262
Salva come PNG Salva come JPEG
Città #
Singapore 5.069
Hong Kong 4.659
Moscow 4.247
Dallas 4.154
San Jose 3.094
Ashburn 2.581
Shanghai 1.839
Hefei 1.802
Lawrence 1.711
Princeton 1.706
Lauterbourg 1.526
Ho Chi Minh City 1.320
Milan 834
New York 806
Beijing 785
Hanoi 745
São Paulo 674
Los Angeles 453
Helsinki 412
Santa Clara 341
Rome 292
Rio de Janeiro 264
Dublin 234
Council Bluffs 229
Boardman 215
Orem 194
Nuremberg 193
Belo Horizonte 184
Munich 184
Da Nang 170
Brasília 159
Brooklyn 158
Montreal 152
Warsaw 147
Tokyo 142
Chicago 141
Haiphong 137
Guangzhou 133
Porto Alegre 126
Johannesburg 123
Chennai 120
Curitiba 120
Denver 119
Turin 117
Naples 113
Mexico City 112
Atlanta 111
Frankfurt am Main 107
Quito 103
Guayaquil 98
Houston 97
Toronto 97
Campinas 96
London 96
Salvador 96
Baghdad 94
Turku 93
Tianjin 91
Stockholm 90
Biên Hòa 87
Bologna 85
Thái Bình 85
Tashkent 84
Phoenix 81
Valencia 81
Guarulhos 80
Hải Dương 78
Poplar 78
Ribeirão Preto 78
Washington 78
Amsterdam 76
Pune 76
Vienna 76
Florence 75
Manchester 75
Seattle 75
Buffalo 72
Manaus 72
Mumbai 72
Dhaka 71
Hangzhou 69
Boston 68
Buenos Aires 65
Jakarta 65
Kuala Lumpur 63
Fortaleza 62
Lima 61
The Dalles 61
Bogotá 60
Caxias do Sul 60
Paris 59
Goiânia 58
San Francisco 57
Erbil 54
New Delhi 54
Santo André 54
Nairobi 53
Cape Town 52
Ninh Bình 52
Changsha 51
Totale 47.118
Salva come PNG Salva come JPEG
Nome #
External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection 2.007
(11)C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms 1.433
Benign Prostatic Hyperplasia and Its Aetiologies 478
Women's sexual dysfunction: a pathophysiological review 314
Impact of prostate imaging quality (PI-QUAL) score on the detection of clinically significant prostate cancer at biopsy 245
Sexual dysfunction is common in women with lower urinary tract symptoms and urinary incontinence: Results of a cross-sectional study 228
Indications for Pelvic Nodal Treatment in Prostate Cancer Should Change. Validation of the Roach Formula in a Large Extended Nodal Dissection Series 227
A comparative review of apomorphine formulations for erectile dysfunction - Recommendations for use in the elderly 226
Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease 216
[18F]Fluoro-Deoxy-Glucose positron emission tomography to evaluate lymph node involvement in patients with muscle-invasive bladder cancer receiving neoadjuvant pembrolizumab 214
11C-choline PET/CT predicts prostate cancer-specific survival in patients with biochemical failure during androgen-deprivation therapy 191
Pelvic/Retroperitoneal Salvage Lymph Node Dissection for Patients Treated With Radical Prostatectomy With Biochemical Recurrence and Nodal Recurrence Detected by [11C]Choline Positron Emission Tomography/Computed Tomography 188
[68Ga]Ga-PSMA and [68Ga]Ga-RM2 PET/MRI vs. Histopathological Images in Prostate Cancer: A New Workflow for Spatial Co-Registration 185
Updated Nomogram Predicting Lymph Node Invasion in Patients with Prostate Cancer Undergoing Extended Pelvic Lymph Node Dissection: The Essential Importance of Percentage of Positive Cores 176
A comprehensive assessment of frailty status on surgical, functional and oncologic outcomes in patients treated with partial nephrectomy––A large, retrospective, single-center study 171
11C-choline PET/CT predicts survival in prostate cancer patients with PSA < 1 NG/ml 167
Role of [68Ga]Ga-PSMA-11 PET radiomics to predict post-surgical ISUP grade in primary prostate cancer 162
[11C]choline positron emission tomography/computerized tomography to restage prostate cancer cases with biochemical failure after radical prostatectomy and no disease evidence on conventional imaging 162
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 161
68Ga-PSMA and 68Ga-DOTA-RM2 PET/MRI in Recurrent Prostate Cancer: Diagnostic Performance and Association with Clinical and Histopathological Data 160
Association between erectile dysfunction and coronary artery disease: Matching the right target with the right test in the right patient 159
A NOVEL MODEL INTEGRATING CLINICAL, MP-MRI, AND EPIGENOMIC FEATURES TO PREDICT LYMPH NODE INVASION IN PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY AND PELVIC LYMPH NODE DISSECTION 158
[C-11]Choline PET/CT predicts survival in hormone-naive prostate cancer patients with biochemical failure after radical prostatectomy 158
A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation 151
Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard 150
Lymphatic spread of nodal metastases in high-risk prostate cancer: The ascending pathway from the pelvis to the retroperitoneum 149
A mechanistic insight into the anti-metastatic role of the prostate specific antigen 149
[ 11C] Choline PET/CT Predicts Prostate Cancer-Specific Survival in Patients with Biochemical Failure During Androgen Deprivation Therapy 145
How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series 144
Survival Effect of Nephroureterectomy in Metastatic Upper Urinary Tract Urothelial Carcinoma 142
11C-CHOLINE-POSITRON EMISSION TOMOGRAPHY/ COMPUTERISED TOMOGRAPHY FOR PREOPERATIVE LYMPH- NODE STAGING IN INTERMEDIATE-RISK AND HIGH-RISK PROSTATE CANCER: COMPARISON WITH CLINICAL STAGING NOMOGRAMS 141
120-MONTH MEDIAN FOLLOW-UP OF INTRACAVERNOUS INJECTION THERAPY FOR ERECTILE DYSFUNCTION 140
[11C]CHOLINE PET/CT SCAN PREDICTS SURVIVAL IN PROSTATE CANCER PATIENTS WITH BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY 139
Efficacy and toxicity of antibody-drug conjugates in the treatment of metastatic urothelial cancer: A scoping review 138
Accurate prediction of long-term risk of biochemical failure after salvage radiotherapy including the impact of pelvic node irradiation 137
Pelvic lymph node dissection in prostate cancer 136
68Ga-PSMA-PET/CT Scan as Primary Staging for Prostate Cancer and Its Related Clinical Implications 136
A propensity score approach for treatment evaluation based on Bayesian Networks 136
Neglected lymph nodal metastases in patients with renal cancer: when to extend the anatomical template of lymph node dissection during nephrectomy 135
Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer 134
Quantitative sensory testing of peripheral thresholds in patients with lifelong premature ejaculation: a case-controlled study 133
A nomogram for staging of exclusive nonobturator lymph node metastases in men with localized prostate cancer 133
Acute Kidney Injury at Hospital Admission for SARS-CoV-2 Infection as a Marker of Poor Prognosis: Clinical Implications for Triage Risk Stratification 133
The Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Assessment of Local Recurrence and Distant Metastases in Patients with Biochemical Recurrence of Prostate Cancer After Definitive Treatment: A Systematic Review and Meta-analysis 132
Does diabetes mellitus increase the risk of high-grade prostate cancer in patients undergoing radical prostatectomy? 132
A CRITICAL APPRAISAL OF THE ABILITY OF BODY MASS INDEX (BMI) TO PREDICT HIGH-GRADE PROSTATE CANCER (PCA) 132
Accuracy of Transurethral Resection of the Bladder in Detecting Variant Histology of Bladder Cancer Compared with Radical Cystectomy 132
How to Select the Optimal Candidates for Renal Mass Biopsy 132
18F-FDG PET/CT and urothelial carcinoma: Impact on management and prognosis—a multicenter retrospective study 131
Contemporary Techniques of Prostate Dissection for Robot-assisted Prostatectomy 130
Preoperative risk calculator for the probability of completing nephron sparing for kidney cancer 129
Holmium laser enucleation of the prostate versus open prostatectomy for prostates > 70 g: 24-month follow-up 129
A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies 129
ROBOT-ASSISTED RADICAL PROSTATECTOMY IS ASSOCIATED WITH FASTER AND GREATER RECOVERY FROM ORGASM ASSOCIATED INCONTINENCE 129
[C-11] Choline Positron Emission Tomography/Computerized Tomography for Early Detection of Prostate Cancer Recurrence in Patients with Low Increasing Prostate Specific Antigen 129
Prediction of Functional Outcomes After Nerve-Sparing Radical Prostatectomy: Results of Conditional Survival Analyses 128
[11C]CHOLINE PET/CT for Early Detection of Tumor in Prostate Cancer Patients with PSA Level Lower Than 1.5 NG/ML 128
Age and gleason score upgrading between prostate biopsy and radical prostatectomy: Is this still true in the multiparametric resonance imaging era? 127
Assessing in-hospital morbidity after urethroplasty using the European Association of Urology Quality Criteria for standardized reporting 127
Holmium Laser Enucleation of the Prostate Is Associated with Complications and Sequelae Even in the Hands of an Experienced Surgeon Following Completion of the Learning Curve 126
Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study 126
Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study 126
Impact of Early Dorsal Venous Complex Ligation on Urinary Continence Recovery after Robot-assisted Radical Prostatectomy: Results from a Phase 3 Randomized Controlled Trial 125
Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool 125
Use of 18F-fluoro-2-deoxy-d-glucose (18F-FDG) PET/CT for lymph node assessment before radical cystectomy in bladder cancer patients 125
Preliminary results of an ongoing prospective clinical trial on the use of68ga-psma and68ga-dota-rm2 pet/mri in staging of high-risk prostate cancer patients 125
Pembrolizumab in advanced renal cell carcinoma: a meta-analysis providing level 1a evidence 124
30-DAY MORTALITY AFTER RADICAL PROSTATECTOMY IN OVER 9000 PATIENTS: VALIDATION OF A PREDICTIVE NOMOGRAM 124
Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinoma 123
Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer 123
Positive Predictive Value of Prostate Imaging Reporting and Data System Version 2 for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis 123
Does previous prostate surgery affect multiparametric magnetic resonance imaging accuracy in detecting clinically significant prostate cancer? Results from a single institution series 122
Diagnostic accuracy of fully hybrid [68Ga]Ga-PSMA-11 PET/MRI and [68Ga]Ga-RM2 PET/MRI in patients with biochemically recurrent prostate cancer: a prospective single-center phase II clinical trial 122
A critical analysis of Permixon (TM) in the treatment of lower urinary tract symptoms due to benign prostatic enlargement 122
Association Between Human Papillomavirus Infection and Outcome of Perioperative Nodal Radiotherapy for Penile Carcinoma 121
Predictors of PSMA PET Positivity: Analysis in a Selected Cohort of Biochemical Recurrence Prostate Cancer Patients after Radical Prostatectomy 120
How to optimize the use of adjuvant pembrolizumab in renal cell carcinoma: which patients benefit the most? 120
Radiomic and gEnomic approaches for the enhanced DIagnosis of clear cell REnal Cancer (REDIRECt): a translational pilot methodological study 118
Time for action: actinium-225 PSMA-targeted alpha therapy for metastatic prostate cancer – a systematic review and meta-analysis 118
Long-term functional outcomes in patients undergoing radical nephrectomy for renal cell carcinoma and tumor thrombus 118
A MINIMUM OF 14 CORES SHOULD BE TAKEN AT BIOPSY BEFORE PLANNING ACTIVE SURVEILLANCE FOR PATIENTS WITH LOW-RISK PROSTATE CANCER 118
18F-FDG PET/CT AND UROTHELIAL CARCINOMA: IMPACT ON MANAGEMENT AND PROGNOSIS—A MULTICENTER RETROSPECTIVE STUDY IN BOOK ROLE OF MEDICAL IMAGING IN CANCERS 117
Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis 117
Defining the optimal target-to-background ratio to identify positive lymph nodes in prostate cancer patients undergoing robot-assisted [99mTc]Tc-PSMA radioguided surgery: updated results and ad interim analyses of a prospective phase II study 117
Impact of lymphovascular invasion on survival in surgically treated upper tract urothelial carcinoma: a nationwide analysis 116
Prostate-specific antigen velocity versus prostate-specific antigen doubling time for prediction of 11C choline PET/CT in prostate cancer patients with biochemical failure after radical prostatectomy 116
[11C]choline PET/CT for the detection of tumor recurrence in prostate cancer patients with PSA<1.5 ng/mL 116
A risk calculator predicting recurrence in lymph node metastatic penile cancer 116
The impact of intraoperative bleeding on the risk of chronic kidney disease after nephron-sparing surgery 116
Does the administration of preoperative pembrolizumab lead to sustained remission post-cystectomy? First survival outcomes from the PURE-01 study☆ 116
Iron Induces Cell Death and Strengthens the Efficacy of Antiandrogen Therapy in Prostate Cancer Models 116
Impact of prostate MRI central review over the diagnostic performance of MRI-targeted biopsy: should we routinely ask for an expert second opinion? 115
A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma 115
Comparison between small renal masses 0-2 cm vs. 2.1-4 cm in size: A population-based study 115
Optimizing prostate-targeted biopsy schemes in men with multiple mpMRI visible lesions: should we target all suspicious areas? Results of a two institution series 115
Supplementary Data from Iron Induces Cell Death and Strengthens the Efficacy of Antiandrogen Therapy in Prostate Cancer Models 114
Variability of mpMRI diagnostic performance according to the upfront individual patient risk of having clinically significant prostate cancer 114
[11C]CHOLINE PET/CT FOR RESTAGING PROSTATE CANCER PATIENTS WITH BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMY AND NO EVIDENCE OF DISEASE ON CONVENTIONAL IMAGING 114
Which Patients with Prostate Cancer and Lymph Node Uptake at Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computerized Tomography Scan Are at a Higher Risk of Prostate-specific Antigen Persistence After Radical Prostatectomy? Identifying Indicators of Systemic Disease by Integrating Clinical, Magnetic Resonance Imaging, and Functional Imaging Parameters 112
Head-to-head comparison of all the prognostic models recommended by the European Association of Urology Guidelines to predict oncologic outcomes in patients with renal cell carcinoma 112
Totale 17.546
Salva come PNG Salva come JPEG
Categoria #
all - tutte 708.842
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 708.842
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.069 0 46 34 464 59 58 95 67 33 60 43 110
2022/20238.183 3.961 1.456 485 71 52 805 299 458 256 84 137 119
2023/20243.873 149 212 329 296 296 576 217 374 84 317 466 557
2024/202521.942 3.054 566 362 532 501 1.790 2.795 1.625 4.145 3.497 1.417 1.658
2025/202665.808 4.410 5.879 6.281 10.078 4.210 1.508 5.653 4.235 16.316 3.268 1.885 2.085
2026/20271.014 1.014 0 0 0 0 0 0 0 0 0 0 0
Totale 102.652